Kyle B. Matchett
Impact in
- Pharmaceutical Science top 10%
- Advancements in Transdermal Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 3
- Epigenetics and DNA Methylation 3
- Nuclear Structure and Function 3
- DNA Repair Mechanisms 2
- Protein Degradation and Inhibitors 2
- Cell death mechanisms and regulation 2
-
- Cancer Genomics and Diagnostics 3
- Co-authors
- Mohamed El‐Tanani (9 shared papers)Ahmed Faheem (5 shared papers)Terence R.J. Lappin (3 shared papers)Paul A. McCarron (4 shared papers)Yusuf A. Haggag (3 shared papers)James A. L. Brown (2 shared papers)Niamh Lynam‐Lennon (2 shared papers)Helen O. McCarthy (2 shared papers)
- Journals
- Oncotarget (4 papers)Cancer Research (2 papers)Cancers (2 papers)Scientific Reports (2 papers)Journal of Further and Higher Education (1 paper)
- Partner nations
- United KingdomIrelandUnited States
In The Last Decade
Kyle B. Matchett
26 papers receiving 448 citations
Peers
Comparison fields: 5 of 84
- Pharmaceutical Science 38
- Cancer Research 49
- Molecular Biology 221
- Biomaterials 43
- Hematology 34
Countries citing papers authored by Kyle B. Matchett
This map shows the geographic impact of Kyle B. Matchett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle B. Matchett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle B. Matchett more than expected).
Fields of papers citing papers by Kyle B. Matchett
This network shows the impact of papers produced by Kyle B. Matchett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle B. Matchett. The network helps show where Kyle B. Matchett may publish in the future.
Co-authors
The 25 scholars most cited alongside Kyle B. Matchett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 48 | |
| 2 | 2017 | 47 | |
| 3 | 2019 | 37 | |
| 4 | 2020 | 32 | |
| 5 | 2014 | 29 | |
| 6 | 2016 | 29 | |
| 7 | 2017 | 28 | |
| 8 | 2018 | 26 | |
| 9 | 2017 | 25 | |
| 10 | 2015 | 24 | |
| 11 | 2023 | 17 | |
| 12 | 2021 | 15 | |
| 13 | 2018 | 14 | |
| 14 | 2016 | 14 | |
| 15 | 2015 | 9 | |
| 16 | 2020 | 8 | |
| 17 | 2014 | 8 | |
| 18 | 2023 | 8 | |
| 19 | 2016 | 7 | |
| 20 | 2017 | 6 |
About Kyle B. Matchett
Kyle B. Matchett is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Hematology and Oncology, having authored 26 papers that have together received 451 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (3 papers), RNA Interference and Gene Delivery (3 papers), Acute Myeloid Leukemia Research (3 papers), Epigenetics and DNA Methylation (3 papers), Nuclear Structure and Function (3 papers), DNA Repair Mechanisms (2 papers), Protein Degradation and Inhibitors (2 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Pharmaceutical Science (38 citations), Cancer Research (49 citations), Molecular Biology (221 citations), Biomaterials (43 citations) and Hematology (34 citations). Kyle B. Matchett has collaborated with scholars based in United Kingdom, Ireland and United States. Frequent co-authors include Mohamed El‐Tanani, Ahmed Faheem, Terence R.J. Lappin, Paul A. McCarron, Yusuf A. Haggag, James A. L. Brown, Niamh Lynam‐Lennon, Helen O. McCarthy, Suzanne McFarlane and Gareth W. Davison. Their work appears in journals such as Oncotarget, Cancer Research, Cancers, Scientific Reports and Journal of Further and Higher Education.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.